{"ticker": {"uuid": "18eeb359-d4d6-4854-8669-eef267d0fcd2", "symbol": "BIOM3", "name": "Biomm S.A.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Biocon and Biomm forge alliance to bring semaglutide diabetes treatment to Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQOHdDWF9MWlBWaFMzQVlvbmI2MkZqdUFFc0lQZkhCVE5IbTFBcjZYSC1xbW5oUUQtU0RlTS0yaUloNjRDd0U0SUJKeEpOYzdMTnJ2eUtWbnBPcmtMY1Z5S2djUGlaZjZVcjJpVk1GWUd5aTBlNW9FcDZTQUQybGlBNW0xSUlTWjAwN0duZ0hHYzVlYVdtYjc2TkdYenp1bjA0V3VPUXVDUU5Rd2YzSExIalBlQXlDcFk?oc=5", "source_name": "Generics and Biosimilars Initiative", "published_at": "2024-06-12T19:20:14+00:00", "published_display": "12 Jun 2024 19:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2024-04-18T07:00:00+00:00", "published_display": "18 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocon partners Biomm to commercialise diabetes drug in Brazil", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2024-04-17T07:00:00+00:00", "published_display": "17 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, a Stelara\u00ae Biosimilar", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxNdjMyMURPZ0lhVFM1LWNyR0JiaWlYcnFDX08tWXVsakVYY29YYzNyZHdkTEJ2a01vTUh5TUlDc0lWWU5OVVRJa09obnJlRzhQMDlCMDMwcUVVUE9ZSkozVVFuNHVPMmNuVkxwbDA3a2hYajl3LUw3eG4zdGdfc21NcFBQTGxQZXd1eDFfLVVLb2NsLTRpTHA2cmFsejRNQUFTM25ZT2lRMzJES3BNZUY4YmVWaEZyOVJlb2pTMVhRaVdldncyV0JZWUZrOGtwcVVWYW5XUkRYV3VSYWw5VjlUM3NDbU9YVW0zV3VPWjM1UXpETFBrcEE?oc=5", "source_name": "Business Wire", "published_at": "2023-06-16T07:00:00+00:00", "published_display": "16 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil - Lupin | Press Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbDgtMlJ6Z0lhazRTTVYwbE9ZNzdmbGdBQnhWYTNMVHpCbE15NHNjVlJjalRBMl8tdmVhd3RGemRwYjFQdUtMVnY5M19pQnNtYUhxdDVTLWd0TzdXTTlLRkVYQ19DWGlQYlFtTk9PWjdSenVpWV93YW5iX2NTQVFsajdiOUxRMmRKR1F1NHNXNmJVaWpfVGNIMzEtNWRROF85bDBWektjVmx2OHhLTGZqU3QtZGItZmlfc0hEZ2dURFNvX2wtY3Y2NHpRODJRVmxwcFE?oc=5", "source_name": "lupin.com", "published_at": "2021-12-03T08:00:00+00:00", "published_display": "03 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Thera Solutions Partners with Biomm to Market BAT1706 in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNT2stNkM1c1JuSllXaS1CTktWZE91czl4RFNqSjJYR19zZHlsa3V6dzBlN0tvMVRZdnJVdGtEek1oYmdka0F3UzZPVXlrdWJleXgwaU9oZV9qTnhEamNUM3FvVHFvSW1Ea0Q0MUwxSzRralBMbzhZbXowck5NeG14Z1F1UnRVaFkzemQyRnN0OVpRdHpOa3JkMUhpZ0hmZjR0RlJfR3hJUnZlQXJ2dFp2ZFpqWmRPXzRPeG1OXzd1S2VlZw?oc=5", "source_name": "Business Wire", "published_at": "2020-12-17T08:00:00+00:00", "published_display": "17 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Biocon and Biomm forge alliance to bring semaglutide diabetes treatment to Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQOHdDWF9MWlBWaFMzQVlvbmI2MkZqdUFFc0lQZkhCVE5IbTFBcjZYSC1xbW5oUUQtU0RlTS0yaUloNjRDd0U0SUJKeEpOYzdMTnJ2eUtWbnBPcmtMY1Z5S2djUGlaZjZVcjJpVk1GWUd5aTBlNW9FcDZTQUQybGlBNW0xSUlTWjAwN0duZ0hHYzVlYVdtYjc2TkdYenp1bjA0V3VPUXVDUU5Rd2YzSExIalBlQXlDcFk?oc=5", "source_name": "Generics and Biosimilars Initiative", "published_at": "2024-06-12T19:20:14+00:00", "published_display": "12 Jun 2024 19:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2024-04-18T07:00:00+00:00", "published_display": "18 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biocon partners Biomm to commercialise diabetes drug in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYVRrX2d3OXZiLTA1SkZHVERINVNKSTNKV1RCMWwyTmVXTDUybzJqYUdjTjJfUWNUQVF2bU9oM29wM1BhTWFQVjdNUWo1WElyYlUwQUFhOHB3SnQ5a3E4RmtoOGNrMVRkY2xBcjFxYWFjTlM1TFRkTmp3c1pjOEZYNDhqV1VTdGNBYlYzV19Wb1VjUU43UFgwX2JoZHVVYjNkQ0NYQWh2NmlyMnBDN2FyZnYyVGRRMU9hWF82aC1mUHhnZFowVk5HVmQ3LUctaWR6akg3TVFCdnNDTjhE0gHiAUFVX3lxTE1JM0JVRW4tVlExbkVUWFBLWlRDSjJhdmJ0ODdjOTR1Mjlvdk16aEVRN3lNd1NVTE14U1FoWUxDYWJxc1JPYzNqdlBYOFljMHJVeG0zTWZQSEdXR3IzVTNWUEJuYkJwUkdiQWM2aUNNSU5SXzdENGNwUndDZ0hFSWVIY0JxOVEyUVpZdUE3MVJRWEhJVjhFd2Z1UDV1eUUxeGxvakY4Z3NZQXZuSXNJcFZTLXgzc1JuNWxmdF84NGNOUzhvZmpzc3JtVWMxY0JzeFBNRHZpd1ZSNHdCTzI4dkZQLXc?oc=5", "source_name": "The Economic Times", "published_at": "2024-04-17T07:00:00+00:00", "published_display": "17 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Thera Solutions Expands Partnership with Biomm in Brazil with Addition of BAT2206, a Stelara\u00ae Biosimilar", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxNdjMyMURPZ0lhVFM1LWNyR0JiaWlYcnFDX08tWXVsakVYY29YYzNyZHdkTEJ2a01vTUh5TUlDc0lWWU5OVVRJa09obnJlRzhQMDlCMDMwcUVVUE9ZSkozVVFuNHVPMmNuVkxwbDA3a2hYajl3LUw3eG4zdGdfc21NcFBQTGxQZXd1eDFfLVVLb2NsLTRpTHA2cmFsejRNQUFTM25ZT2lRMzJES3BNZUY4YmVWaEZyOVJlb2pTMVhRaVdldncyV0JZWUZrOGtwcVVWYW5XUkRYV3VSYWw5VjlUM3NDbU9YVW0zV3VPWjM1UXpETFBrcEE?oc=5", "source_name": "Business Wire", "published_at": "2023-06-16T07:00:00+00:00", "published_display": "16 Jun 2023 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil - Lupin | Press Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbDgtMlJ6Z0lhazRTTVYwbE9ZNzdmbGdBQnhWYTNMVHpCbE15NHNjVlJjalRBMl8tdmVhd3RGemRwYjFQdUtMVnY5M19pQnNtYUhxdDVTLWd0TzdXTTlLRkVYQ19DWGlQYlFtTk9PWjdSenVpWV93YW5iX2NTQVFsajdiOUxRMmRKR1F1NHNXNmJVaWpfVGNIMzEtNWRROF85bDBWektjVmx2OHhLTGZqU3QtZGItZmlfc0hEZ2dURFNvX2wtY3Y2NHpRODJRVmxwcFE?oc=5", "source_name": "lupin.com", "published_at": "2021-12-03T08:00:00+00:00", "published_display": "03 Dec 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bio-Thera Solutions Partners with Biomm to Market BAT1706 in Brazil", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNT2stNkM1c1JuSllXaS1CTktWZE91czl4RFNqSjJYR19zZHlsa3V6dzBlN0tvMVRZdnJVdGtEek1oYmdka0F3UzZPVXlrdWJleXgwaU9oZV9qTnhEamNUM3FvVHFvSW1Ea0Q0MUwxSzRralBMbzhZbXowck5NeG14Z1F1UnRVaFkzemQyRnN0OVpRdHpOa3JkMUhpZ0hmZjR0RlJfR3hJUnZlQXJ2dFp2ZFpqWmRPXzRPeG1OXzd1S2VlZw?oc=5", "source_name": "Business Wire", "published_at": "2020-12-17T08:00:00+00:00", "published_display": "17 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 6, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 5, "score": 52, "total": 6, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 2.55, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 1.45, "count": 2}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 6.2, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -7.5, "twelve_week_move": -18.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.931297, "market_dynamics_buy_signal": false, "relative_strength": -24.353751, "fair_value_gap": -26.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.951, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -7.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Business Wire", "count": 2}, {"label": "Generics and Biosimilars Initiative", "count": 1}, {"label": "Business Standard", "count": 1}, {"label": "The Economic Times", "count": 1}, {"label": "lupin.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 6}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "6", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -7.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Biocon and Biomm forge alliance to bring semaglutide diabetes treatment to Brazil"}], "updated_at": "2026-07-18T06:35:00.524852+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}